Text Size

Creativity Group for Borderline Personality Disorder

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by State University of New York - Upstate Medical University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier:
NCT01343550
First received: April 26, 2011
Last updated: April 27, 2011
Last verified: February 2011
History of Changes
  Purpose

The investigators hypothesize that a creativity skills group for Borderline Personality Disorder can reduce symptoms of BPD, depression, and anxiety.


Condition Intervention Phase
Borderline Personality Disorder
 Other: creativity group
 Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Creativity Group for Borderline Personality Disorder

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by State University of New York - Upstate Medical University:

Primary Outcome Measures:
  • Borderline Evaluation of Severity Over Time (BEST) [ Time Frame: baseline, 5th week, post-intervention (week 8) ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Beck Depression Inventory (BDI) [ Time Frame: baseline, week 5, week 8 ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: February 2011
Estimated Study Completion Date: August 2011
Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Creativity group for persons diagnosed with BPD Other: creativity group
This is a creativity group intervention. There will be 4 groups. Each group has one session per week. Each session is a duration of two hours.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • participant self-reports clinical diagnosis of Borderline Personality Disorder
  • currently seeing an individual therapist on a regular basis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01343550

Contacts
Contact: Blake Bazel, M.S. 315-464-3144 bazelb@upstate.edu
Contact: Robbi Saletsky, Ph.D. 315-464-3165 saletsrt@upstate.edu

Locations
United States, New York
SUNY Upstate Medical University Recruiting
Syracuse, New York, United States, 13210
Sub-Investigator: Blake Bazel, M.S.            
Sub-Investigator: Robbi Saletsky, Ph.D.            
Sub-Investigator: Roger Greenberg, Ph.D.            
Principal Investigator: Robert Gregory, M.D.            
Sponsors and Collaborators
State University of New York - Upstate Medical University
Investigators
Study Director: Blake Bazel, M.S. State University of New York - Upstate Medical University
Study Director: Robbi Saletsky, Ph.D. State University of New York - Upstate Medical University
Study Director: Roger Greenberg, Ph.D. State University of New York - Upstate Medical University
  More Information

Publications:

Responsible Party: Robert Gregory, M.D., SUNY Upstate Medical University
ClinicalTrials.gov Identifier: NCT01343550     History of Changes
Other Study ID Numbers: PHS6019
Study First Received: April 26, 2011
Last Updated: April 27, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by State University of New York - Upstate Medical University:
Borderline Personality Disorder
Borderline Personality
Borderline

Additional relevant MeSH terms:
Personality Disorders
Borderline Personality Disorder
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013